glutamic acid decarboxylase ( gad ) activity in cerebrospinal fluid ( csf ) was determined in 53 patients with neurological diseases as follows : epilepsy ( n:17 ) , febrile convulsions ( n:3 ) , meningoencephalitis ( n:17 ) , encephalopathies ( n:10 ) , cns leukemia ( n:3 ) , congenital hydrocephalus ( n:2 ) and pseudoileus neonatorum ( n:1 ) .
C0014544
epilepsy
C0009952
febrile convulsions